Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
开发可被肿瘤表达的蛋白酶激活的减毒白细胞介素-2融合蛋白
期刊:Immunology
影响因子:4.9
doi:10.1111/j.1365-2567.2011.03428.x
John Puskas, Denise Skrombolas, Abigail Sedlacek, Edith Lord, Mark Sullivan, John Frelinger
